Funding for this research was provided by:
Received: 7 December 2020
Accepted: 1 March 2021
First Online: 12 March 2021
: Not applicable.
: The patient gave permission to the publication of her clinical case. The identifiable personal details were omitted.
: SS received travel expenses for educational events not related to the topic from Gilead, ViiV and Abbvie; JR received honoraria for consulting or speaking at educational events. Gilead, Janssen, Merck, Theratechnologies and ViiV outside the submitted work. All other authors declare that they have no competing interests.